Total Payments
$59,003
2024 Payments
$9,197
Companies
8
Transactions
114
Medicare Patients
125
Medicare Billing
$11,094
Payment Breakdown by Category
Other$28,165 (47.7%)
Travel$28,088 (47.6%)
Food & Beverage$2,481 (4.2%)
Education$268.98 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $28,088 | 63 | 47.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,165 | 15 | 39.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $5,000 | 3 | 8.5% |
| Food and Beverage | $2,481 | 30 | 4.2% |
| Education | $268.98 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Exelixis Inc. | $57,549 | 102 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $693.26 | 3 | $0 (2024) |
| ABBVIE INC. | $279.76 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $107.56 | 1 | $0 (2024) |
| Genentech, Inc. | $102.72 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $102.03 | 1 | $0 (2023) |
| Amgen Inc. | $99.00 | 1 | $0 (2022) |
| Seagen Inc. | $69.99 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,197 | 24 | Exelixis Inc. ($8,384) |
| 2023 | $21,167 | 42 | Exelixis Inc. ($20,924) |
| 2022 | $28,592 | 47 | Exelixis Inc. ($28,241) |
| 2021 | $45.88 | 1 | AbbVie Inc. ($45.88) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $63.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/21/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/15/2024 | Exelixis Inc. | CABOMETYX (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,250.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/10/2024 | Genentech, Inc. | Alecensa (Biological) | Food and Beverage | In-kind items and services | $102.72 | General |
| Category: BioOncology | ||||||
| 10/01/2024 | Exelixis Inc. | CABOMETYX (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/01/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | Cash or cash equivalent | $30.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/01/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | Cash or cash equivalent | $24.93 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/01/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | Cash or cash equivalent | $24.12 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/01/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | Cash or cash equivalent | $13.46 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/01/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | Cash or cash equivalent | $10.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/01/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | Cash or cash equivalent | $7.93 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 09/25/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $490.50 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 09/24/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $65.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 09/20/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $185.94 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 09/19/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 09/06/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $483.98 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 09/06/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $377.97 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 09/06/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $70.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 09/06/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $70.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 04/09/2024 | Exelixis Inc. | CABOMETYX (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,750.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 03/28/2024 | Exelixis Inc. | CABOMETYX (Drug) | Travel and Lodging | In-kind items and services | $1,253.49 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 03/27/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 02/08/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $107.56 | General |
| 01/25/2024 | Ipsen Biopharmaceuticals, Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $540.00 | General |
| 12/05/2023 | Exelixis Inc. | CABOMETYX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 33 | 40 | $10,008 | $2,790 |
| 2022 | 1 | 27 | 45 | $9,675 | $2,514 |
| 2021 | 1 | 20 | 35 | $7,525 | $2,273 |
| 2020 | 1 | 45 | 73 | $14,161 | $3,518 |
Total Patients
125
Total Services
193
Medicare Billing
$11,094
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 16 | $4,848 | $1,477 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 18 | 24 | $5,160 | $1,312 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 27 | 45 | $9,675 | $2,514 | 26.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 20 | 35 | $7,525 | $2,273 | 30.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 45 | 73 | $14,161 | $3,518 | 24.8% |
About Olivia Ogburn, NP
Olivia Ogburn, NP is a Nurse Practitioner healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2017. The National Provider Identifier (NPI) number assigned to this provider is 1770023145.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Olivia Ogburn, NP has received a total of $59,003 in payments from pharmaceutical and medical device companies, with $9,197 received in 2024. These payments were reported across 114 transactions from 8 companies. The most common payment nature is "Travel and Lodging" ($28,088).
As a Medicare-enrolled provider, Ogburn has provided services to 125 Medicare beneficiaries, totaling 193 services with total Medicare billing of $11,094. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Winston Salem, NC
- Active Since 03/03/2017
- Last Updated 03/03/2017
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1770023145
Products in Payments
- CABOMETYX (Drug) $29,208
- Cabometyx (Drug) $28,241
- CREON (Drug) $160.53
- Alecensa (Biological) $102.72
- Stivarga (Drug) $102.03
- SOMATULINE DEPOT (Drug) $81.36
- Onivyde (Drug) $71.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Winston Salem
Mary Sands, Np, NP
Nurse Practitioner — Payments: $31,321
Nurse Practitioner $31,321
Christine Zdeb, Np, NP
Nurse Practitioner — Payments: $11,906
Nurse Practitioner $11,906
Eileen Tague, Np, NP
Nurse Practitioner — Payments: $7,571
Nurse Practitioner $7,571
Jennifer Davis, Agnp-C, AGNP-C
Nurse Practitioner — Payments: $6,979
Nurse Practitioner $6,979
Lillykutty Modoor, Nurse Practitioner, NURSE PRACTITIONER
Nurse Practitioner — Payments: $6,334
Nurse Practitioner $6,334
Dr. Charles Cook, Dnp, DNP
Nurse Practitioner — Payments: $5,968
Nurse Practitioner $5,968